Biotechnology Faculty

Dr. Annica Wayman, Ph.D. | Acting Graduate Program Director and Associate Dean

Ph.D., Mechanical Engineering, Georgia Institute of Technology
M.S., Mechanical Engineering, Georgia Institute of Technology
B.S., Mechanical Engineering, UMBC

Show more

Dr. Annica Wayman is the Associate Dean for Shady Grove Affairs in the College of Natural and Mathematical Sciences (CNMS) for UMBC. She is responsible for administering and directing the undergraduate Translational Life Sciences Technology (TLST) program and Master of Professional Studies in Biotechnology at the Universities at Shady Grove (USG).

Dr. Wayman received her B.S. in Mechanical Engineering from UMBC and Ph.D. and M.S. in Mechanical Engineering from the Georgia Institute of Technology. Her research focus at Georgia Tech was on selectin-mediated cell adhesion. Following Georgia Tech, Dr. Wayman worked at Becton, Dickinson & Co. (BD) where she served in various R&D engineering roles ranging from advanced technology development to new product development for their anesthesia platform. Immediately prior to her UMBC appointment as Associate Dean, she was Division Chief of the Research Partnerships for Development unit in the Global Development Lab at the United States Agency for International Development (USAID) where her team managed scientific research policies and programs for the agency and its more than 90 field offices worldwide and developed research partnerships with higher education institutions, federal science agencies, global development institutions, and private sector companies.

Sanjeev Ahuja, Ph.D. | Graduate Faculty

Ph.D., Chemical and Biochemical Engineering, UMBC
M.S., Biochemical Engineering and Biotechnology, Indian Institute of Technology

Show more

Sanjeev Ahuja joined the Biotechnology program as an instructor in 2008. As Senior Scientist in MedImmune’s Process Cell Culture department in Gaithersburg, MD, he manages process development, scale up, scale down, commercial support, and technology development in support of mammalian cell culture processes.

He is equally involved in applying statistical principles to development of cell culture processes and data mining techniques to enhance the understanding of commercial bioprocesses. Prior to joining MedImmune, Dr. Ahuja had extensive experience in various aspects of development and commercialization of upstream processes including bacterial fermentation, mammalian cell culture, and associated primary recovery unit operations at Biogen Idec, Human Genome Sciences, and Baxter Healthcare Corporation. He primarily teaches BTEC 652: Applied Bioprocess Engineering. Additionally, he is Six Sigma certified, has one patent, and is published in a variety of journals.

View Dr. Ahuja’s public LinkedIn profile.

Concetta Dudley | Graduate Faculty

J.D., Cleveland-Marshall College of Law at Cleveland State University
M.B.E., Perelman School of Medicine at the University of Pennsylvania
B.A., Case Western Reserve University

Show more

Concetta E. Dudley is an accomplished attorney and bioethicist. She brings nearly three decades of legal experience to her role as General Counsel for Inspirion Biosciences, which provides biorisk management and strategy services. In addition to her current in-house role, Ms. Dudley has served in a number of senior positions in industry, government and academia, including with the National Institutes of Health, Johns Hopkins University, and MedImmune (now an Astra Zeneca company). She has expertise in corporate and technology transactions, start-up and emerging companies, strategic business advising, corporate compliance, and conflict management. Ms. Dudley also holds adjunct graduate faculty positions at the University of Maryland, Baltimore County, and the Johns Hopkins University and teaching technology transfer and commercialization, as well as legal, ethical and regulatory aspects of biotechnology, at the graduate level. Ms. Dudley received her JD from the Cleveland-Marshall College of Law at Cleveland State University, her Master of Bioethics from the Perelman School of Medicine at the University of Pennsylvania, and her Bachelors degree from Case Western Reserve University. Admissions Supreme Court of the United States Supreme Court of Ohio.

Greg Hamilton, Ph.D. | Adjunct Instructor

Ph.D., Chemistry, University of Virginia
M.P.S., Biotechnology, UMBC
B.S., Biological Chemistry, University of Virginia

Show more

Dr. Hamilton has been an instructor in the MPS Biotechnology program at UMBC since 2017. He has over thirty years of experience in the pharma and biotech industries, both in R&D and in intellectual property management. His experience in pharma/biotech research spans several therapeutic areas and multiple companies. He was Vice-President of Chemistry at Guilford Pharmaceuticals, Inc. and Artesian Therapeutics, Inc. before joining MGI PHARMA (subsequently Eisai Inc.) as Sr. Director of Intellectual Property. Compounds of his invention have entered human clinical trials for Parkinson’s Disease, erectile dysfunction following radical prostatectomy, congestive heart failure, and wound healing.

Dr. Hamilton has a bachelor’s degree in Biological Chemistry, and a Ph.D. in Chemistry (natural products total synthesis), both from the University of Virginia, and has been a member of the US patent bar since 2004. He also has an MPS degree in Biotechnology from UMBC. He is founding editor and co-editor-in-chief of the journal Central Nervous System Agents: Medicinal Chemistry. He is currently Director of Chemistry and Intellectual Property at Acidophil LLC, a Baltimore area biotechnology incubator shop.

Keith R. Kirkwood | Adjunct Instructor

M.S., Engineering Management, UMBC, 2014
B.S., Computer Information Systems, Eastern Washington University
Graduate, U.S. Army Computer Science School

Show more

Mr. Kirkwood has almost 30 years of leadership and management experience in both industry and the U.S. Army. He is currently an Engineering Program Manager for Northrop Grumman Electronic Systems in Linthicum, MD. He has been with Northrop Grumman for 18 years in a variety of leadership and management positions. His assignments include serving as the Communications Integrated Product Team lead for the Tactical Exploitation System, Department Systems Engineering Manager for the C4ISR Department, Lead Systems Engineer and Chief Engineer for the Distributed Common Ground System – Army (Version 4), and the manager for the Processing Architectures Department in the Advanced Concepts & Technology Division. Keith has also served as technical business development engineer and has been a functional manager for the previous 9 years.

Prior to joining Northrop Grumman, Keith served as a Cavalry officer and a Systems Automation Acquisition officer for the United States Army for 11 years. As an acquisition officer, he was responsible for the software lifecycle management for the All Source Analysis System (ASAS). As a Cavalry officer, Keith was fortunate to be able to witness firsthand the fall of the East-West German border.

Keith’s principal areas of interest include cyber security, system of systems engineering, processing architectures, intelligence processing systems, component based software engineering and model driven engineering.

Kevin Knapstein | Adjunct Instructor

Master of Engineering, University of Maryland, College Park
B.S., Physiology, University of Maryland, College Park
B.S., Biological Resources Engineering, University of Maryland, College Park

Show more

Kevin Knapstein has over 12 years of experience in upstream process development, technology transfer, and biotech curriculum development. In his role as the Manager within the Biotechnology Research and Education Program (BREP) at the University of Maryland, he provided upstream process development, scale-up, and tech transfer for a variety of biotech clients in the pre-clinical workspace. In addition, he has over 10 years of experience developing course curriculums for undergraduate and graduate engineering courses with a focus on practical biotechnology and biopharmaceutical engineering applications.

Kevin received a B.S. in Biological Resources Engineering, B.S. in Physiology, and a Master of Engineering all from the University of Maryland – College Park.

Scott Krygier | Adjunct Instructor

Antonio Moreira | Vice Provost, Graduate Faculty

Ph.D., Chemical and Biochemical Engineering, University of Pennsylvania
M.S., Chemical and Biochemical Engineering, University of Pennsylvania
B.S., Chemical Engineering, University of Porto, Portugal

Show more

Antonio Moreira is the Vice Provost for Academic Affairs and a professor of Chemical and Biochemical Engineering at University of Maryland, Baltimore County. Dr. Moreira has both previous (Schering-Plough Corporation) and ongoing biotechnology industry contacts and experience. He draws from first-hand work in research and development, scale-up and introduction to commercialization of biotechnology products, such alpha interferon. Dr. Moreira has an active research program in bioprocess engineering and is a consultant to various biotechnology and pharmaceutical companies.

He has received various awards including a NATO Senior Fellowship and the James Aggalloco Award from the Parenteral Drug Association. He served as the President for the Chesapeake Bay Area Chapter of the International Society for Pharmaceutical Engineering; he is immediate past-chair of the Council for Biotechnology Centers for the BIO Industry Organization, and serves on scientific advisory boards for various organizations. Dr. Moreira is Chairman of Peritus Consultants, Inc. an international consulting corporation. He is also a graduate of Leadership Maryland, class of 1998.

He received his B.S. in Chemical Engineering from the University of Porto in Portugal and his M.S. and Ph.D. in Chemical and Biochemical Engineering from the University of Pennsylvania. Dr. Moreira is the Graduate Program Director for the Graduate Certificate in Biochemical Regulatory Engineering. He currently teaches BTEC 660: Regulatory Issues in Biotechnology and BTEC 662: Good Manufacturing Practices and Bioprocesses.

View Dr. Moreira’s public LinkedIn profile.

Irina Ramos | Adjunct Instructor

Ph.D., Chemical and Biochemical Engineering, UMBC
B.S., Chemical Engineering, University of Oporto

Show more

Irina Ramos has over 7 years of experience in Biopharmaceutical Downstream Processing Development. As Scientist in MedImmune’s Purification Process Sciences department in Gaithersburg, MD, she manages downstream process development and optimization, scale up, technology transfer activities into cGMP manufacturing to supply clinical trials and contributes to regulatory submissions.

Dr. Ramos received her B.S. in Chemical Engineering from the University of Oporto, School of Engineering and her Ph.D. in Chemical and Biochemical Engineering from UMBC. She primarily teaches BTEC 653.

View Dr. Ramos’ LinkedIn profile.

Dvorah Richman

Dvorah A. Richman | Adjunct Professor

J.D., The Catholic University of America 
M.A., Communications Disorders, The University of Denver 
B.S., Speech Pathology, Arizona State University 

Show more

Dvorah Richman is a regulatory attorney with extensive industry and law firm experience focused on  Food and Drug Administration (FDA) laws, regulations and policies relating to medical devices.  She currently consults, speaks and writes about FDA and related matters. 

Ms. Richman served as in-house and outside regulatory counsel to FDA-regulated companies for over 35 years. Her most recent industry position was V.P., Chief Regulatory Counsel to Siemens Healthineers, a leading global medical technology company.  Prior positions included FDA and Regulatory Counsel to Life Technologies, Senior Regulatory Counsel to Olympus Corporation of the Americas and Partner with the law firm of King & Spalding.   

She brings regulatory and legal expertise regarding a wide range of products and topics including imaging devices, in vitro diagnostics, artificial intelligence, product promotion, clinical studies, privacy, government enforcement and fraud and abuse.

Ms. Richman has considerable real world experience in many areas of legal/regulatory practice including: drafting corporate policies and procedures; analyzing business plans; commenting on proposed government rules; drafting and negotiating contracts; conducting  due diligence for mergers and acquisitions; facilitating product approvals; analyzing proposed legislation; managing crises; and developing litigation strategy and  briefs for administrative law cases.  She has conducted many corporate seminars on diverse regulatory, compliance and legal topics, spoken at industry conferences and authored articles for various publications.   

She earned her B.S. degree in Speech Pathology from Arizona State University, her M.A. in Communications Disorders from the University of Denver and her J.D.  from the Catholic University of America.  

Mark Schenerman, Ph.D | Adjunct Professor

Ph.D., Biochemistry and Molecular Biology, University of Florida
B.S., Medical Technology, University of Maryland

Show more

Dr. Mark Schenerman is currently President of a consulting firm (CMC Biotech-MAS Consulting) that he founded and is advising academic, industry, and regulatory agency groups. He is also a Professor of the Practice of Biotechnology at the University of Maryland. He is an experienced biopharmaceutical scientist and executive who has most recently been responsible for developing and aligning cross-functionally Chemistry, Manufacturing, & Control (CMC) strategy leading to global regulatory filings (IND through BLA) at MedImmune/AstraZeneca. Dr. Schenerman was also responsible for maintaining and building key collaborations externally with peer biopharmaceutical companies, academic institutions, and government agencies to advance regulatory science. Prior to this, Dr. Schenerman headed an R&D group that performed structural and biological characterization of preclinical and clinical products, stability and release testing, technology transfer to quality control and ongoing product development support. Since joining MedImmune in 1994, Dr. Schenerman played an integral role in developing and leading the company’s Analytical Biochemistry function, supporting all stages of product development.

Prior to joining MedImmune, Dr. Schenerman held positions in biologics development and research and development at Bristol-Myers Squibb Company and was a post-doctoral fellow at Cornell University. He earned his Bachelor’s degree in Medical Technology at the University of Maryland and his doctorate in Biochemistry and Molecular Biology at the University of Florida.

Looking for more info?